Journals / Türk Nefroloji Diyaliz ve Transplantasyon Dergisi / 2008 / Cilt: 17 - Sayı: 3

Coronary artery disease risk factors in patients on continuous ambulatory peritoneal dialysis

Sürekli ayaktan periton diyalizi uygulanan hastalarda koroner arter hastalığı risk faktörleri

Pages
106–112
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Because of the high rates of increased risk factors for coronary artery disease in CAPD patients at early stages, these patients should be closely followed for coronary artery disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: We aimed to investigate especially early stage non traditional cardiovascular risk factors in end stage renal failure patients who were in Continued Ambulatory Peritoneal Dialysis (CAPD) programme in our center.
📊
Key Findings & Data:Methods: In this study 21 CAPD patients and 21 sex and age matched controls were enrolled.
💡
Conclusion & Impact:Conclusion: Because of the high rates of increased risk factors for coronary artery disease in CAPD patients at early stages, these patients should be closely followed for coronary artery disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: We aimed to investigate especially early stage non traditional cardiovascular risk factors in end stage renal failure patients who were in Continued Ambulatory Peritoneal Dialysis (CAPD) programme in our center. Methods: In this study 21 CAPD patients and 21 sex and age matched controls were enrolled. The clinical history and demographic parameters were obtained and than for physical evaluation blood samples were drawn for 12 hours fasting glucose, serum total cholesterol, HDL- cholesterol, LDL- cholesterol, triglyceride, apoA, apoB, total protein, albumin, calcium, phosphorus, parathormon (PTH), hemoglobin (Hb), Lp(a), C-reactive protein (CRP), homocysteine (tHcy), anticardiolipin antibody (ACLA), fibrinogen. Results: While age, sex, Body Mass Index (BMI), smoking status and hereditary factors were comparable between the groups, diabetes mellitus and hypertension were significantly higher in CAPD patients. There was no statistical significance between the groups considering mean serum total cholesterol, HDL- cholesterol, LDLcholesterol, triglyceride, PTH, Lp(a), tHcy, ACLA Ig M and ACLA Ig G levels. In the present study mean apoA level was significantly lower in the study group, while apoB and phosphorus were higher (p=0.003). Also mean total protein, albumin, calcium, and Hb level were significantly lower, while mean CRP and fibrinogen were higher in the study group (p=0.0003). Conclusion: Because of the high rates of increased risk factors for coronary artery disease in CAPD patients at early stages, these patients should be closely followed for coronary artery disease.

Özet

Amaç: Bu çalışmada merkezimizde son dönem böbrek yetmezliğ i tanısı konularak sürekli ayaktan periton diyalizi (SAPD) uyguladığı mız hastalarımızdaki özellikle geleneksel olmayan kardiyovasküler risk faktörlerini erken dönemde araştırmayı amaçladık. Materyal ve Metod: Çalışmaya 21 SAPD hastası ile kontrol grubu olarak yaş ve cinsiyetleri uyumlu 21 sağlıklı birey alındı. Olguları n demografik özellikleri ve anamnezleri alındıktan sonra fizik muayeneleri yapıldı. 12 saatlik açlık sonrası açlık kan şekeri, serum total kolesterol, HDL-kolesterol, LDL-kolesterol, trigliserit, apoA, apoB, total protein, albümin, kalsiyum, fosfor, parathormon (PTH), hemoglobin (Hb), Lp(a), C-reaktif protein (CRP), homosistein (tHcy), antikardiyolipin antikorları (ACLA), fibrinojen için kan örneği alındı. Bulgular: Gruplar arasında yaş, cinsiyet, vücut kitle indeksi (BMI) sigara içimi, heredite açısından fark bulunmazken, diabetes mellitus (DM) ve hipertansiyon (HT) SAPD hastalarında anlamlı olarak yüksek bulundu. Total kolesterol, HDL-kolesterol, LDL-kolesterol, trigliserit, PTH, Lp(a), tHcy, ACLA IgM ve IgG’nin ortalama değerleri arasında istatistiksel olarak anlamlı fark bulunmadı. Çalışmamızda apoA’nın düşüklüğü, apoB ve fosforun yüksekliği istatistiksel olarak anlamlıydı (p=0.03). Ortalama total protein, albümin, kalsiyum, Hb’nin düşüklüğü, CRP ve fibrinojenin yüksekliği kontrol grubuna göre istatistiksel olarak anlamlı bulundu (p=0.0003). Sonuç: SAPD olgularının erken dönemde yüksek KAH risk faktörleri ile karşı karşıya olması nedeniyle, KAH açısından yakın takibi gerekmektedir.

🔖

Cite This Article

BORAZAN, A., KUVANDIK, G., SÖKMEN, C., UÇAR, E., POÇAN, B., GÜVEN, O., CAMIZCI, R., İLİKHAN, S., ÜNSAL, B., GÜRSÜRER, M. (2022). Coronary artery disease risk factors in patients on continuous ambulatory peritoneal dialysis. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, Cilt: 17 - Sayı: 3, 106–112. https://ajindex.com/articles/636512

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. DOQ1 and NKF. Chronic Kidney Disease as a public health problem. Am J Kidney Dis 2002;39:17-31
  2. Rattazzi M, Puato M, Faggin E, et al. New markers of accelerated atherosclerosis in end-stage renal disease. J Nephrol 2003;16:11-20
  3. Sarnak MJ. Cardiovascular complications in chronic kidney disease. Am J Kidney Dis 2003;41:S11-S17
  4. Cheung AK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risk in chronic hemodialysis patient. Kidney Int 2000;58:353-362
  5. Emin Yılmaz ME, Kara ‹H, Alan S. Hemodiyaliz hastalarında kardiyovasküler mortalite ve diğer risk faktörlerinin değerlendirilmesi. Dicle Tıp Dergisi 2001;28:151-161
  6. Eikelboom JW, Hankey GJ. Associations of homocysteine, Crective protein and cardiovascular disease in patients with renal disease. Curr Opin Nephrol Hypertens 2001;10:377-383
  7. Zimmermann J, Herrlinger S, Pruy A, et al. Inşammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-658
  8. Murphy SW, Foley RN, Parfey PJ. National kidney foundation task force on cardiovascular disease:screening and treatment for cardiovascular disease in patients with chronic renal disease. Am J Kidney Dis 1998;32:184-199
  9. Sechi LA, Zingaro L, De Carli S, et al. Increased serum lipoprotein(a) levels in patients with early renal failure. Ann Intern Med 1998;129:457-461
  10. Kronenberg F, Utermann G, Dieplinger H. Lipoprotein (a) in renal disease. Am J Kidney Dis 1996;27:1-25
  11. Danesh J, Collins R, Peto R. Lipoprotein (a) and coronary heart disease: Meta-analysis of Prospective Studies. Circulation 200;102:1082-1085
  12. Dieghan CJ, Caslake MJ, McConnell M, et al. Atherogenic lipoprotein phenotype in end-stage renal failure: origin and extend of small dense low-density lipoprotein formation. Am J Kidney Dis 2000;35:852-862
  13. Asmann G, Schulte H. Resuits and conclusions of the Prospective Cardiovascular Munster (PROCAM) Study in: G. Assmann (ed). Lipid Metabolism Disorders and Coronary Heart Disease. München, MMV Medizin Verlag, 1989;p:96
  14. McLean JW, Tomlinson JE, Lawn RM, et al. cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 1987;330:132-137
  15. Bostom AG, Cupples LA, Jenner JL, et al. Elevated plasma lipoprotein (a) and coronary heart disease in men aged 55 years and younger. JAMA 1996;276:544-548
  16. Mahley RW, Weisgraber KH, Innerarity TL, Rall SC. Genetic defects in lipoprotein metabolism. Elevation of atherogenic lipoproteins caused by impa